The global transplantation
market is expected to reach USD 51.0 billion by the year 2025, growing
at a CAGR of 9.1%, according to a new report by Grand View Research, Inc.
Growing incidence of organ failure has resulted in massive growth in the
transplantation market. Rising demand for transplant products such as tissue
products, immunosuppressants, and organ preservation solutions is a major
factor anticipated to boost growth of the market during forecast period. Thus,
many biotechnology and medical device companies have begun to concentrate on
the development of advanced transplant products for management of organ
failure.
Technological advancement in organ transplantation
methods is another major factor supporting the market growth. The development
of novel & improved transplant products such as tissue products and
surgical instruments has majorly contributed to the expansion of the sector. In
addition, introduction of advanced tissue products such as DeNovo NT Graft,
Chondrofix Osteochondral Allograft, and DuraMatrix Collagen Dura
Substitute Membrane provides higher benefits during treatment. In
addition, computerized support systems with advanced systems and software allow
easy & effective maintenance of tissues. Thus, availability of such
advanced techniques supports increase in the number of organ transplant
procedures.
Browse full research report on Transplantation Market: https://www.grandviewresearch.com/industry-analysis/transplantation-market
Further
key findings from the report suggest:
- Tissue products segment was the largest revenue-generating amongst
others due to escalating number of tissue and organ transplant procedures
- Tissue products segment is also expected to grow at highest CAGR
owing to advancement in transplantation products
- Tissue transplant segment held the largest revenue share in the
market, because of rising number of skin, bones, heart valves, cornea,
tendons, nerves, and veins procedures worldwide
- The transplant centers segment is projected to grow at the highest
CAGR during the forecast period owing to rising popularity of these
centers for transplant procedures
- The hospitals segment dominated the market in terms of revenue in
2016 owing to a large number of transplant procedures performed in
hospitals
- North America was the leading regional sector in 2016 and is
projected to maintain its dominance during the forecast period owing to
well-developed healthcare infrastructure
- Existence of large number of research laboratories, biotechnology,
and medical device companies in the North America region is the major
factor contributing to its large share
- Some of the major players include AbbVie, Inc.; Arthrex, Inc.;
Zimmer Biomet; Medtronic; Novartis AG; Stryker; 21st Century Medicine;
BioLifeSolutions, Inc; Teva Pharmaceuticals; and Veloxis Pharmaceuticals.
Browse more reports of this category
by Grand View Research: https://www.grandviewresearch.com/industry/biotechnology
Grand
View Research has segmented the global transplantation market on the basis of
product, application, end-use, and region:
Product
Outlook (Revenue, USD Billion; 2014 - 2025)
- Tissue
products
- Immunosuppressive
drugs
- Preservation
solutions
Application
Outlook (Revenue, USD Billion; 2014 - 2025)
- Organ
transplantation
- Tissue
transplantation
End-Use
Outlook (Revenue, USD Billion; 2014 - 2025)
- Hospitals
- Transplant
centers
- Others
Regional
Outlook (Revenue, USD Billion; 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- Mexico
- MEA
- South Africa
About Grand View
Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
No comments:
Post a Comment